New trial aims to save rectums in rectal cancer patients
NCT ID NCT06952101
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a personalized, stage-based approach to treat rectal cancer while trying to avoid removing the rectum. 200 participants will receive either experimental chemoradiotherapy or minimally invasive surgery depending on their cancer stage. The goal is to preserve the rectum and improve quality of life without compromising cancer control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
chemoradiotherapy (experimental and standard), minimally invasive surgery (laparoscopic/robotic)
What this could lead to
If successful, this could offer a way to treat rectal cancer without removing the rectum, preserving bowel function and quality of life for many patients.
What could go wrong
This is an early-phase study with only 200 participants, so results may not apply to everyone. The organ-sparing approach may not work for all patients, and some may still need surgery or face cancer recurrence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Department of Surgical Oncology - FPO-IRCCS Institute for Cancer Research and Treatment
RECRUITINGCandiolo, Turin, 10060, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact